Oral Ruxolitinib Treatment for Patients With Dermatologic Manifestations of Acute or Chronic Graft-Versus-Host Disease (GVHD): A Post Hoc Analysis of the Phase 3 REACH2 and REACH3 Studies-MedSci.cn

Oral Ruxolitinib Treatment for Patients With Dermatologic Manifestations of Acute or Chronic Graft-Versus-Host Disease (GVHD): A Post Hoc Analysis of the Phase 3 REACH2 and REACH3 Studies

Choi, JN; Bhatt, V; Galvin, J; Tian, C; Zeiser, R

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023; 89 (3): AB202

科室
- - 订阅+
  - 更多科室
工具
服务